Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jul;85(3):655-63.
doi: 10.1111/j.1476-5381.1985.tb10561.x.

Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants

Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants

P Leff et al. Br J Pharmacol. 1985 Jul.

Abstract

The operational model of agonism (Black & Leff, 1983) has been used to analyse comparatively functional antagonism and irreversible antagonism as methods for estimating agonist dissociation constants (KAs). A general condition is established in terms of the model parameters which defines the type of experimental interventions at the receptor and the post-receptor level that allow valid KA estimation. It is shown that functional antagonism and other post-receptor interventions may produce changes in agonist-concentration effect curves which are qualitatively indistinguishable but quantitatively distinct, from those produced by irreversible antagonism. Experimental data obtained with the guinea-pig tracheal strip preparation are in keeping with the theoretical predictions and show how studies using functional antagonism may overestimate agonist affinity. In general, functional antagonism, unlike irreversible antagonism, is in principle an unreliable method for quantifying agonism.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Eur J Pharmacol. 1971 Jan;13(2):218-29 - PubMed
    1. Br J Pharmacol Chemother. 1967 Sep;31(1):188-96 - PubMed
    1. Eur J Pharmacol. 1973 Jun;22(3):270-8 - PubMed
    1. Eur J Pharmacol. 1974 Oct;28(2):251-6 - PubMed
    1. J Pharmacol Exp Ther. 1975 Sep;194(3):554-64 - PubMed

LinkOut - more resources